Elixirr International (CHIX:ELIXL) Research & Development: £0.0 Mil (TTM As of Dec. 2025)


CHIX:ELIXL Elixirr International PLC CHIX:ELIXL
71 GF Score
Price £7.04
GF Value £10.59
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Elixirr International Research & Development?

Elixirr International CHIX:ELIXL +0.57% 71 Research & Development is £0.0 Mil as of Dec. 2025. GuruFocus rates CHIX:ELIXL with a GF Score™ of 71/100 and a GF Value™ of £10.59 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Elixirr International's Research & Development for the six months ended in Dec. 2025 was £0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was £0.0 Mil.

Elixirr International  (CHIX:ELIXl) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Elixirr International Research & Development Related Terms

Elixirr International Research & Development Historical Data

* Premium members only.

The historical data trend for Elixirr International's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixirr International Research & Development Chart

Elixirr International Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Elixirr International Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:ELIXL
71GF Score
Elixirr International PLC CHIX:ELIXL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elixirr International Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.0 Mil mean?
Elixirr International (CHIX:ELIXL) has a Research & Development of £0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Elixirr International and its competitors.
Is Elixirr International's Research & Development too high?
Elixirr International's current Research & Development is £0.0 Mil. Overall, Elixirr International has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elixirr International's Research & Development compare to VRSK and EFX?
Elixirr International's Research & Development of £0.0 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Business Services company?
A good Research & Development depends on the Business Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Elixirr International and its competitors. Elixirr International's current Research & Development is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixirr International stock overvalued right now?
Based on GuruFocus' analysis, Elixirr International (CHIX:ELIXL) is currently considered Significantly Undervalued. The stock's GF Value™ is £10.59, compared to a current price of £7.04 — trading 33.5% below its estimated fair value. The current Research & Development is £0.0 Mil. Elixirr International's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Elixirr International (CHIX:ELIXL), the current Research & Development is £0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elixirr International (CHIX:ELIXL) Overvalued in 2026?

Based on GuruFocus' analysis, Elixirr International stock appears to be undervalued. The current stock price of £7.04 is trading 33.5% below its estimated GF Value™ of £10.59. GuruFocus considers Elixirr International to be Significantly Undervalued.

Key valuation signals for CHIX:ELIXL:

  • Research & Development: £0.0 Mil
  • GF Value™: £10.59 vs. price of £7.04 (33.5% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ELIXL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elixirr International Business Description

Other Exchanges ELXXF:USAELIX:UK54K:Germany
Address 100 Cheapside, London, GBR, EC2V 6DT
Elixirr International PLC is a provider of management consultancy services. The company is principally engaged in the provision of consulting services, delivering original and bespoke solutions to a globally-recognized client base, including creative, marketing and transformation services. These challenges include future proofing against technological disruption development and roll-out of new products, services and businesses navigating a more complex and multinational regulatory environment; and project management and implementation of change programs. Geographically, the company operates in United Kingdom; USA; and Rest of the World, of which USA derives maximum revenue.
71GF Score

Get the complete analysis for CHIX:ELIXL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£7.04
Price
£10.59
GF Value